Review Article

The Diagnostic and Differential Diagnosis Utility of Cerebrospinal Fluid α-Synuclein Levels in Parkinson’s Disease: A Meta-Analysis

Table 1

Summary of studies included in the systematic review.

AuthorYearDetection methodPDControlMSADLBPSAReferences
CSFCSFCSFCSFCSF
α-syn (ng/mL)α-syn (ng/mL)α-syn (ng/mL)α-syn (ng/mL)α-syn (ng/mL)

Parnetti2014ELISA4422.15 (11.86–38.64)2536.5 (25.8–49.6)[15]
Parnetti2014ELISA7122.00 (13.50–38.60)4539.67 (27.72–64.60)[16]
Mondello2014ELISA520.84 (0.69–1.01)221.31 (0.94–1.5)340.75 (0.64–1.06)320.98 (0.79–1.2)[17]
Van Dijk2014TR-FRET immunoassay531.48 ± 0.41501.70 ± 0.47 [18]
Mollenhauer2013ELISA781.339 ± 0.236481.504 ± 0.337[19]
Aerts2012ELISA5826.0 (20.5–32.5)5725.0 (18.0–42.0)4725 (17–32)2424 (23–34)[20]
Wang2012Luminex830.389 ± 0.137510.520 ± 0.130140.330 ± 0.120300.42 ± 0.186 [21]
1090.399 ± 0.137710.487 ± 0.181200.319 ± 0.114220.419 ± 0.120
Shi2011Luminex1260.38 ± 0.101370.49 ± 0.17200.30 ± 0.09[22]
Parnetti2011ELISA3843.1 ± 473268.9 ± 713218.1 ± 16[23]
Mollenhauer2011ELISA2731.34 ± 0.81232.22 ± 1.31151.11 ± 0.45661.32 ± 0.6281.78 ± 0.91 [24]
511.19 ± 0.81761.73 ± 1.83291.24 ± 0.99551.42 ± 1.26
Hong2010Luminex800.36 ± 0.10910.47 ± 0.16[25]
Öhrfelt2009ELISA150.417 (0.246–0.522)550.395 (0.298–0.452)150.334 (0.220–0.406)[26]